International Journal of Radiation Oncology*Biology*Physics

Journal Information
ISSN / EISSN : 0360-3016 / 1879-355X
Current Publisher: Elsevier BV (10.1016)
Total articles ≅ 71,271
Current Coverage
SCOPUS
PUBMED
MEDLINE
MEDICUS
SCIE
COMPENDEX
Archived in
SHERPA/ROMEO
EBSCO
Filter:

Latest articles in this journal

International Journal of Radiation Oncology*Biology*Physics, Volume 109, pp 36-37; doi:10.1016/j.ijrobp.2020.07.2314

The publisher has not yet granted permission to display this abstract.
International Journal of Radiation Oncology*Biology*Physics, Volume 109; doi:10.1016/s0360-3016(20)34512-0

Alejandra Méndez Romero , Wilco Schillemans, Rob Van Os, Friederike Koppe, Cornelis J. Haasbeek, Ellen M. Hendriksen, Karin Muller, Heleen M. Ceha, Pètra M. Braam, Onne Reerink, et al.
International Journal of Radiation Oncology*Biology*Physics; doi:10.1016/j.ijrobp.2020.11.045

Olatz Garin, José Francisco Suárez, Ferran Guedea, Àngels Pont, Yolanda Pardo, Alai Goñi, Alfonso Mariño, Asunción Hervás, Ismael Herruzo, Patricia Cabrera, et al.
International Journal of Radiation Oncology*Biology*Physics; doi:10.1016/j.ijrobp.2020.12.032

Abstract:
Long-term comparative effectiveness research of localized prostate cancer treatments is scarce, evidence lacking specially for brachytherapy. The aim of this study was to assess the long-term impact of the side effects of radical prostatectomy, brachytherapy, and external radiotherapy on patients with localized prostate cancer at 10 years, using propensity score analyses. This was a prospective observational study of a cohort of men diagnosed with clinically localized prostate cancer (clinical stage T1 or T2, low and intermediate risk group), and treated with: radical prostatectomy (n=192), brachytherapy (n= 317) or external radiotherapy (n=195). Treatment election was jointly made by patients and physicians. Patient-Reported Outcomes (PRO) evaluation included the Expanded Prostate Cancer Index Composite (EPIC) and the Short Form-36, administered centrally by telephone interviews before and annually after treatment. EPIC covers urinary, bowel, sexual, and hormonal domains. To assess PRO changes over time, while accounting for correlation among repeated measures, generalized Estimating Equation (GEE) models adjusted by propensity score were constructed. PROs completion rate at 10 years was 85.8%. GEE models showed that the pattern of radical prostatectomy's side effects, with large urinary incontinence and sexual dysfunction, remained until ten years after treatment: -1.1 and -1.3 standard deviations (SD). Brachytherapy produced late deterioration on urinary continence (-0.4 SD) and sexual function (-0.9 SD) that appeared at mid-term, but differences from radical prostatectomy remained statistically significant at 10 years (p
Andrew J. Frankart, Michael J. Frankart, Brian Cervenka, Alice L. Tang, Deepak G. Krishnan, Vinita Takiar
International Journal of Radiation Oncology*Biology*Physics; doi:10.1016/j.ijrobp.2020.12.043

Minh-Phuong Huynh-Le , Michelle D. Tibbs, Roshan Karunamuni, Kathryn R. Tringale, Mia Salans, Anthony Yip, Michael Connor, Aaron B. Simon, Lucas K. Vitzthum, Anny Reyes, et al.
International Journal of Radiation Oncology*Biology*Physics; doi:10.1016/j.ijrobp.2020.12.046

Hans Liew, Stewart Mein, Ivana Dokic, Thomas Haberer, Jürgen Debus, Amir Abdollahi, Andrea Mairani
International Journal of Radiation Oncology*Biology*Physics; doi:10.1016/j.ijrobp.2020.12.048

Joseph K. Salama , Scott R. Floyd, Christopher G. Willett, David G. Kirsch
International Journal of Radiation Oncology*Biology*Physics; doi:10.1016/j.ijrobp.2020.12.050

A. Köthe , P. Van Luijk, S. Safai, M. Kountouri, A.J. Lomax, D.C. Weber, G. Fattori
International Journal of Radiation Oncology*Biology*Physics; doi:10.1016/j.ijrobp.2020.12.052

Joel S. Bedford , J. Martin Brown
International Journal of Radiation Oncology*Biology*Physics, Volume 109, pp 73-75; doi:10.1016/j.ijrobp.2020.08.041

The publisher has not yet granted permission to display this abstract.
Back to Top Top